The Challenge: Vulnerable Patients and Hospital Readmissions

Older adults, notably those with ⁢frailty and cardiovascular disease, ⁣face significant challenges‌ when ​transitioning from hospital to home. This period is often marked by increased vulnerability, medication complexities, and a higher risk of⁢ readmission. According to the ⁤Australian Institute ⁤of Health and Welfare (AIHW), approximately 1 in 5 patients discharged from⁢ hospital are ​readmitted within 28 days, costing the Australian‍ healthcare system ⁢billions annually. ⁢For those over 75, the‍ readmission rate is even higher.

These readmissions aren’t simply a matter of cost; they represent a decline in patient well-being, ⁢increased morbidity, and a diminished quality of life. Current discharge planning frequently enough lacks​ the personalized support needed ​to address the unique needs of frail, older ‌individuals.

The UOW Research ‍Program: A ⁢New Approach

Professor Caleb Ferguson, a cardiovascular nurse researcher at UOW’s Faculty of Science, Medicine and Healthcare, has secured funding ‍to develop and test a new model⁢ of care.​ The program ‍will focus on a extensive, individualized approach to discharge planning and post-discharge support.

The research ⁢will investigate the‍ effectiveness of a multi-component ‍intervention that ⁣includes:

• Enhanced Discharge Planning: ‌ A detailed assessment of the patient’s needs, including functional capacity, cognitive status, social support, and medication management.
• Personalized Care Plans: Development of tailored⁣ care plans in collaboration ‍with the patient, their family, and healthcare⁣ providers.
• Home-Based ​Support: Provision⁤ of home visits from nurses or allied health professionals⁣ to monitor the patient’s condition, provide medication reconciliation, and address‍ any emerging ⁤issues.
• Telehealth Monitoring: Utilizing remote monitoring technologies to track vital signs and identify potential‍ problems early on.
• Caregiver Education ‍and Support: providing education and support⁢ to family members or⁤ caregivers to empower them to provide effective care.

The study will involve‌ a randomized controlled trial, comparing the ⁤outcomes of patients receiving ⁣the new intervention to those receiving⁤ standard ⁤discharge care. The‌ primary outcome measure will be‌ the rate of hospital readmission within 90 days.

Who Benefits and Why​ It matters

This research directly benefits frail, older adults with heart‌ conditions – ​including those with heart failure, coronary artery disease, and arrhythmias – who are frequently hospitalized. It also extends to their families and caregivers, who ‍often bear a significant burden of care.

Accomplished implementation ⁤of this program could lead to:

• Reduced Hospital readmissions: ​Lowering healthcare costs and improving patient outcomes.
• Improved Quality of Life: Enabling patients ​to maintain their independence and live ​comfortably at ‍home.
• Enhanced Patient Safety: Preventing complications⁢ and adverse events.
• Strengthened Healthcare System: Optimizing resource allocation and improving the efficiency of care delivery.

timeline and Next steps

The research program is​ currently in the planning phase, with recruitment expected to begin in ⁣early 2025. The study⁣ is ​anticipated to run for three years, with results expected